A team of researchers led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device that could transform how blood cancer treatments are tested and tailored for patients.
Go to Source
https://medicalxpress.com/rss-feed/
Go to Source
https://medicalxpress.com/rss-feed/